Loading company…
Barcelona-based Neuraxpharm develops and distributes medicines for central nervous system disorders.
Neuraxpharm Holdco Iberia S.L.U. was founded in 2016 and is headquartered in Barcelona, Spain. Its products cover psychiatric conditions such as anxiety, depression, schizophrenia and bipolar disorder, and neurological conditions such as Alzheimer's disease, multiple sclerosis and epilepsy. It sells mainly through B2B channels to hospitals, clinics and pharmacies, largely in Europe. The company has raised USD 155.00 mn in total, most recently in a deal on July 12, 2022, led by Permira.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in